Calcium Intake and Bone Mineral Density in People With HIV and/or Chronic Hepatitis C. [PDF]
Temesgen ZB, Temesgen Z, Bedimo RJ.
europepmc +1 more source
Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study. [PDF]
Sung BR +7 more
europepmc +1 more source
Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals. [PDF]
Feyissa GD.
europepmc +1 more source
Real-world Effectiveness and Safety of Coblopasvir plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study. [PDF]
Ruan LM +8 more
europepmc +1 more source
Risk of drug-induced liver injury in chronic hepatitis C and tuberculosis co- infection: a systematic review and meta- analysis. [PDF]
Wei X +7 more
europepmc +1 more source
The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir. [PDF]
Kodsi EM +6 more
europepmc +1 more source
Aspartate aminotransferase-to-platelet ratio index (APRI) for staging of fibrosis in adults with chronic hepatitis C. [PDF]
Dreytser E +5 more
europepmc +1 more source
Epidemiological characteristics, genotype patterns, and treatment outcomes in chronic hepatitis C patients receiving direct-acting antivirals: a cohort study from Istanbul, Türkiye. [PDF]
Karaman Kamalı S +4 more
europepmc +1 more source
Injecting Drug Use History and Younger Age Worsen Adherence to Scheduled Hospital Visits in Glecaprevir and Pibrentasvir Therapy for Chronic Hepatitis C. [PDF]
Tawara S +10 more
europepmc +1 more source
Comparison of Noninvasive Methods for the Evaluation of Liver Fibrosis in Children With Chronic Hepatitis C Virus Infection. [PDF]
Pokorska-Śpiewak M +4 more
europepmc +1 more source

